Maybe one thing we can take away from CYDY experie

Maybe one thing we can take away from CYDY experience - supposedly, according to some there, the study was not well designed. Joe has been working meticulously with the FDA to make sure our study is designed per the FDA input - probably the main reason that we are experiencing continuing delays. Based on what just happened this afternoon, maybe it's a good thing that 1) we're trying to supplicate the FDA guidance to the nth degree and 2) we're also pursuing the trials in China where there is perhaps a greater chance of success based on their ineffective vaccines. Don't know if either will be true or not, but just a thought. One thing I do know - losing $500 million in market cap in about 15 minutes is a rough pill to swallow, and I hope and believe Joe is trying to prevent us from seeing a similar result in the future.

Of course, it would be nice to have $500 million in MC to lose...LOL.